Class
Breaking the photosynthetic barrier for 400k species
Immediate yield jumps: 90% in Potatoes, 41% Canola, 24% Sorghum. Coming soon: Poplars, Cotton, Corn, Lettuce

Photosynthesis wastes sunlight. Many scientific efforts are underway to reengineer photosynthesis to increase yields. Climate Crop – 5 years in the making at Weizmann Institute – will outgrow them all.

It works in all vascular plants. It’s simple – downregulating one enzyme. During the day, plants increase their storage of transient starch; at night, they use this starch as building blocks for all cell matter. Climate Crop simply increases the storage of transient starch – then the plant takes it from there.

Climate Crop will power applications across agriculture and industrial markets. Higher yielding cotton. More affordable animal feed. Carbon-sucking poplars. Aviation fuels from rapeseed.

Yehuda Borenstein, CEO
"Our solution is not competitive with other crop science programs. It's additive. It's fast, easy, and we can work on almost all crops."
ClimateCrop raised $525,000 from SOSV and the Genesis Consortium.
Climate Crop
Yehuda Borenstein, CEO
"Our solution is not competitive with other crop science programs. It's additive. It's fast, easy, and we can work on almost all crops."
ClimateCrop raised $525,000 from SOSV and the Genesis Consortium.
Cancer cells feel different. To the touch.
Cellens is at 94% accuracy in detecting bladder cancer from urine. Next up is colorectal, then replacing the PSA score.

In the field of liquid biopsy, the abundance of new technologies are mere screening tests. They can’t monitor patients’ progression and drive clinical decisions. The real money is in monitoring disease patients, for years.

Atomic Force Microscopy scans the surface of cells at such high resolution that it can not only discriminate cancer cells from healthy cells, it can identify the stage and aggressiveness. The scientific community is so excited by Cellens’ work that grant funding is covering all the costs of their pre-clinical trials at Dana Farber, Dartmouth, and UW.

Jean Pham, MS, CEO
“Patients hate the invasiveness of cystoscopies. And urologists have more valuable uses of their time. 90% of them can be eliminated with just a urine sample.”
Cellens has raised $500,000 from SOSV and other angels.
Cellens Inc
Jean Pham, MS, CEO
“Patients hate the invasiveness of cystoscopies. And urologists have more valuable uses of their time. 90% of them can be eliminated with just a urine sample.”
Cellens has raised $500,000 from SOSV and other angels.
Go with your gut
More than 20 MM Americans actively seek non-prescription solutions for their debilitating conditions caused by excessive levels of waste toxins like urate and oxalate. Another 50MM are at risk!

Modern lifestyles are hard on our livers and kidneys, the organs that filter and break down metabolic waste products. But people don’t want to take drugs – they want to get healthy. Unlocked Labs unleashes the power of the microbiome to help out.

Unlocked is a consumer probiotic company that unlocks silent genes – regaining the power to reduce toxins in our bodies.

Some gut microbes have the genes to eat our waste products as food, as a carbon source. These are dormant genes – they can be unlocked and activated. The company’s first products reduce uric acid and oxalic acid. High uric acid leads to gout, and high oxalic acid leads to kidney stones.

Christoph Geisler, PhD, CEO
“The forgotten organ, the microbiome, has the potential to be just as powerful as the liver at detoxifying waste from our bodies.”
Unlocked Labs has raised $525,000 from SOSV and the Genesis Consortium.
Unlocked Labs
Christoph Geisler, PhD, CEO
“The forgotten organ, the microbiome, has the potential to be just as powerful as the liver at detoxifying waste from our bodies.”
Unlocked Labs has raised $525,000 from SOSV and the Genesis Consortium.
The world's fastest protein design & development platform
Plants are 62.5X more efficient than animals at producing proteins

There’s two general concerns around molecular farming, where animal proteins are grown in field crops. First, the extraction and purification. Second, the regulatory landscape for transgenic crops amidst other farmland.

Veloz Bio doesn’t use the farm. And the founders are experts at extraction and membrane purification. Without the need of bioreactors, they can develop and scale up new protein production in less than 6 months.

Enrique Gonzalez, MBA, CEO
"We make high-value proteins by skipping the first 99% of the plant's lifetime. That's how we go 100x faster."
Veloz Bio raised $275,000 from SOSV
Veloz Bio
Enrique Gonzalez, MBA, CEO
"We make high-value proteins by skipping the first 99% of the plant's lifetime. That's how we go 100x faster."
Veloz Bio raised $275,000 from SOSV
Growing where others can't.
33% of our world’s agricultural soil is degraded. Without bold innovation, 90% of soil will be degraded by 2050.

The market value of farmland is driven by yield. For example, increasing soy yield by 10 bushels an acre can double the value of the farmland.

Puna Bio repairs soil health using extremophiles – organisms 3.5 billion years old, sourced from La Puna, the highest and driest desert on Earth. These organisms grow where others can’t – and they sustain plant life, despite getting 1/5th the rainfall of Death Valley.

When an athlete trains at altitude, she is even stronger at sea level. So it is with Puna’s extremophiles. They work wonders on degraded, acidic, and salinated soil. In fertile soil, they boost yields 4x more than competitors, with far more consistent results.

Puna Bio is already at industrial scale, having treated +600 tonnes of seeds this season, and conducted over 20,000 acres of field trials.

Franco Martinez Levis, MBA, CEO
"Degraded soil WILL be the new norm, unless we stop it."
Puna Bio has raised $800,000 from SOSV, Genesis Consortium, and GRID-X.
Puna Bio
Franco Martinez Levis, MBA, CEO
"Degraded soil WILL be the new norm, unless we stop it."
Puna Bio has raised $800,000 from SOSV, Genesis Consortium, and GRID-X.
The world's most powerful and affordable cell media supplement
Serum-free media costs $400/L, and comprises more than 90% of the cost of growing cultured meat.

CellCrine discovered an enzyme that transforms cell culture for the cell-based meats industry.

It’s made recombinantly, but can be used at such low concentration that only a tiny bit is needed.

The impact is dramatic — reducing the need for insulin, transferrin, FGF2, TGFb, and other expensive media ingredients. The cells grow nearly as fast as they do en vivo.

CellCrine’s enzyme works by stimulating cells to make their own growth factors; it also chaperones growth factors to receptors. With muscle cells, they also help myotube formation.

The enzyme is food grade and natural.

Rodolfo Faudoa, MD, CEO
"We've been working on this problem for over a decade, before the cultured meat industry had even considered it a problem. And now we can grow meats 20X cheaper than with serum-free media"
Cellcrine has raised $275,000 from SOSV.
CellCrine
Rodolfo Faudoa, MD, CEO
"We've been working on this problem for over a decade, before the cultured meat industry had even considered it a problem. And now we can grow meats 20X cheaper than with serum-free media"
Cellcrine has raised $275,000 from SOSV.
Capture CO2 while you drive
“Fast” charging is 2-3x more expensive. And not that fast.

Solid Ox is building Range Extenders for commercial fleets of electric trucks and buses. These range extenders use liquid fuel, where the CO2 is captured on board, right back into the fuel tank. Emissions-free.

Commercial fleets that need long range are very price sensitive to fueling costs. They also run day and night, so have short windows to refuel or recharge. Solid Ox allows fleets to refuel in half the time, at half the cost.

Solid Ox has a partnership with Smith Electric Vehicles.

Jared Moore, CEO
"Electric vehicles are coming fast but nobody is talking about the elephant in the room: how slow it is to charge them"
Solid Ox Motors has raised $525,000 from SOSV and Genesis Consortium.
Solid Ox Motors
Jared Moore, CEO
"Electric vehicles are coming fast but nobody is talking about the elephant in the room: how slow it is to charge them"
Solid Ox Motors has raised $525,000 from SOSV and Genesis Consortium.
“Reef safe” isn’t safe. “Reef friendly” isn’t friendly.
14,000 tons of sunscreens enter the ocean each year.

All available sunscreen active ingredients absorb through our skin, interfering with hormones and even exacerbating UV damage. Meanwhile, SPFs in cosmetics, washed down the drain at night, accumulate in sensitive marine environments, where even the “reef safe” versions threaten endangered corals and marine life.

Based on groundbreaking work in protein engineering at Princeton, Soliome has reinvented sunscreens and SPFs, an $18B global market. ​​It is totally safe, long-lasting and goes on clear without white residue.

Why now: In October of 2022, new FDA regulations on sunscreens take effect, dramatically reducing the cost and burden of approval.

Why it’s scalable: Because Soliome can make their SPFs from any protein. Even common plant proteins already used as food.

Micah Nelp, PhD, CEO
“Imagine sunscreens so safe that we could literally eat them, and metabolize them like any plant protein.”
Soliome has raised $525,000, from SOSV and Genesis Consortium
Soliome
Micah Nelp, PhD, CEO
“Imagine sunscreens so safe that we could literally eat them, and metabolize them like any plant protein.”
Soliome has raised $525,000, from SOSV and Genesis Consortium
Selective and targeted insecticide at an unprecedented scale

Pyrone is making the one-step precursor to the world’s most valuable chemicals cheaper than anyone can. The first compound we’ll bring to market is pogostone, a very targeted insecticide.

Pyrone
Targeting RNA with small molecules is a new modality with massive potential to unlock incurable diseases. But the rules remain unclear.
It takes the world's RNA experts years to make an RNA-based biosensor. Wayfinder does it in 2 weeks.

Wayfinder has built a drug discovery platform for small molecules that modulate RNA targets. Their technology generates highly quantitative data on RNA-small molecules interactions at high-throughput. Combined with their AI/ML virtual screening models, they can search billions of molecules for RNA modulators in just 3 days.

And they do it way faster than anyone else in the world. Wayfinder is WAY faster.

A spinout from the Center for Synthetic Biology at the University of Washington, Wayfinder has internal programs in oncology and unique technologies to unlock RNA drugging.

Jason Fontana, PhD, CEO
“Many key drivers of disease remain impossible or extremely challenging to drug today. By targeting at the RNA level, we can prevent disease-proteins from being made in the first place.”
Wayfinder Biosciences has raised $6.8 million, from SOSV, BoxOne, and other investors
Wayfinder Biosciences
Jason Fontana, PhD, CEO
“Many key drivers of disease remain impossible or extremely challenging to drug today. By targeting at the RNA level, we can prevent disease-proteins from being made in the first place.”
Wayfinder Biosciences has raised $6.8 million, from SOSV, BoxOne, and other investors